Synbio Tech Inc. (TPEX:1295)

Market Cap	3.84B
Revenue (ttm)	1.06B
Net Income (ttm)	180.49M
Shares Out	34.48M
EPS (ttm)	5.68
PE Ratio	19.64
Forward PE	16.21
Dividend	3.50 (3.14%)
Ex-Dividend Date	Mar 27, 2025

Volume	290,544
Average Volume	480,023
Open	115.50
Previous Close	115.50
Day's Range	111.50 - 115.50
52-Week Range	58.50 - 157.50
Beta	n/a
RSI	31.83
Earnings Date	Nov 7, 2025

About Synbio Tech

Synbio Tech Inc. manufactures and sells human healthcare products and probiotics for animals. It offers lactobacillus plantarum powder and derivatives of fermented lactic acid bacteria, as well as probiotics for dietary supplements, pets, economic animals, and plant preservation. The company also provides single probiotic strain and multi strain probiotics, and functional strain. Its functional strain includes SynForU-MemoryUp, a solution for brain health; Lactobacillus plantarum TWK10 for exercise performance; ABKEFIR to improve digestive and ...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2000
• Employees: 92
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 1295

Financial Performance

In 2024, Synbio Tech's revenue was 989.48 million, an increase of 20.18% compared to the previous year's 823.30 million. Earnings were 170.13 million, an increase of 50.19%.